...
机译:根据甲状腺过氧化物酶抗体和BRAF V600E V600E突变的存在,弥漫性淋巴细胞浸润和乳头状甲状腺癌侵略性之间的关系
Division of Endocrinology and Metabolism Department of Internal MedicineYonsei University College;
Division of Endocrinology and Metabolism Department of Internal MedicineNational Health Insurance;
Division of Endocrinology and Metabolism Department of Internal MedicineYonsei University College;
Division of Geriatrics Department of Internal MedicineYonsei University College of MedicineSeoul;
Division of Endocrinology and Metabolism Department of Internal MedicineYonsei University College;
Department of SurgeryYonsei University College of MedicineSeoul Republic of Korea;
Department of SurgeryYonsei University College of MedicineSeoul Republic of Korea;
Division of Endocrinology and Metabolism Department of Internal MedicineYonsei University College;
B‐type Raf (BRAF); diffuse lymphocytic infiltration; Hashimoto's thyroiditis; papillary thyroid carcinoma; thyroid peroxidase antibody;
机译:根据甲状腺过氧化物酶抗体和BRAF V600E V600E突变的存在,弥漫性淋巴细胞浸润和乳头状甲状腺癌侵略性之间的关系
机译:BRAF V600E和TERT启动子突变协同识别最激进的乳头状甲状腺癌,其复发最高
机译:预测甲状腺癌突变状态的辐射瘤:使用射线瘤预测乳头状甲状腺癌BRAF V600E突变的初步研究
机译:从概念到诊所的机器学习:使用高尺寸RNA表达数据可靠地检测甲状腺结节中的BRAF V600E DNA突变
机译:使用癌症的基因工程小鼠模型进行BRAF(V600E)诱导的非小细胞肺癌的遗传合作。
机译:BRAF V600E和TERT启动子突变共同确定了复发性最高的最积极的乳头状甲状腺癌
机译:BRAF V600E突变与甲状腺乳头状癌复发之间的关系